+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Diabetic Macular Edema Treatment Market 2018-2022 - Product Image

Global Diabetic Macular Edema Treatment Market 2018-2022

  • ID: 4618183
  • Report
  • August 2018
  • Region: Global
  • 109 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Alimera Sciences
  • ALLERGAN
  • Bausch Health
  • F. Hoffmann-La Roche
  • Regeneron Pharmaceuticals
  • MORE
About Diabetic Macular Edema

Diabetic macular edema is an accumulation of fluid in the macula, a part of the retina that controls most of the detailed vision abilities, due to leaking blood vessels.

The analysts forecast the Global Diabetic Macular Edema Treatment Market to grow at a CAGR of 1.45% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the diabetic macular edema treatment market. To calculate the market size, the report considers the revenue generated by sales of therapeutics for diabetic macular edema across the globe.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, diabetic macular edema treatment market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
  • ALLERGAN
  • Alimera Sciences
  • Bausch Health
  • F. Hoffmann-La Roche
  • Regeneron Pharmaceuticals
Market drivers
  • Increase in R&D investments by pharmaceutical companies
  • For a full, detailed list, view the full report
Market challenges
  • Lack of awareness
  • For a full, detailed list, view the full report
Market trends
  • Use of new laser delivery systems
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the Key vendors in this market space?
  • What are the market opportunities and threats faced by the Key vendors?
  • What are the strengths and weaknesses of the Key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alimera Sciences
  • ALLERGAN
  • Bausch Health
  • F. Hoffmann-La Roche
  • Regeneron Pharmaceuticals
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: PIPELINE LANDSCAPE

PART 08: MARKET SEGMENTATION BY PRODUCT TYPE
  • Segmentation by product type
  • Comparison by product type
  • Anti-VEGF – Market size and forecast 2017-2022
  • Corticosteroid – Market size and forecast 2017-2022
  • Others – Market size and forecast 2017-2022
  • Market opportunity by product type
PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas – Market size and forecast 2017-2022
  • EMEA – Market size and forecast 2017-2022
  • APAC – Market size and forecast 2017-2022
  • Market opportunity
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • ALLERGAN
  • Alimera Sciences
  • Bausch Health
  • F. Hoffmann-La Roche
  • Regeneron Pharmaceuticals
PART 16: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global diabetic macular edema treatment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global diabetic macular edema treatment market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global diabetic macular edema treatment market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Key clinical trial candidates for the treatment of diabetic macular edema
Exhibit 19: Key clinical trial candidates for the treatment of diabetic macular edema
Exhibit 20: Comparison by product type
Exhibit 21: Anti-VEGF – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Anti-VEGF – Year-over-year growth 2018-2022 (%)
Exhibit 23: Corticosteroid – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Corticosteroid – Year-over-year growth 2018-2022 (%)
Exhibit 25: Others – Market size and forecast 2017-2022 ($ mn)
Exhibit 26: Others – Year-over-year growth 2018-2022 (%)
Exhibit 27: Market opportunity by product type
Exhibit 28: Customer landscape
Exhibit 29: Global diabetic macular edema treatment market by geography – Market share 2017-2022 (%)
Exhibit 30: Regional comparison
Exhibit 31: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in Americas
Exhibit 34: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in EMEA
Exhibit 37: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 38: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 39: Top 3 countries in APAC
Exhibit 40: Market opportunity
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: ALLERGAN: Overview
Exhibit 47: ALLERGAN – Business segments
Exhibit 48: ALLERGAN – Organizational development
Exhibit 49: ALLERGAN – Geographic focus
Exhibit 50: ALLERGAN – Segment focus
Exhibit 51: ALLERGAN – Key offerings
Exhibit 52: ALLERGAN – Key customers
Exhibit 53: Alimera Sciences: Overview
Exhibit 54: Alimera Sciences – Business segments
Exhibit 55: Alimera Sciences – Organizational developments
Exhibit 56: Alimera Sciences – Segment focus
Exhibit 57: Alimera Sciences – Key offerings
Exhibit 58: Alimera Sciences – Key customers
Exhibit 59: Bausch Health: Overview
Exhibit 60: Bausch Health – Business segments
Exhibit 61: Bausch Health – Organizational developments
Exhibit 62: Bausch Health – Geographic focus
Exhibit 63: Bausch Health – Segment focus
Exhibit 64: Bausch Health – Key offerings
Exhibit 65: Bausch Health – Key customers
Exhibit 66: F. Hoffmann-La Roche: Overview
Exhibit 67: F. Hoffmann-La Roche – Business segments
Exhibit 68: F. Hoffmann-La Roche – Organizational developments
Exhibit 69: F. Hoffmann-La Roche – Geographic focus
Exhibit 70: F. Hoffmann-La Roche – Segment focus
Exhibit 71: F. Hoffmann-La Roche – Key offerings
Exhibit 72: F. Hoffmann-La Roche – Key customers
Exhibit 73: Regeneron Pharmaceuticals: Overview
Exhibit 74: Regeneron Pharmaceuticals – Business segments
Exhibit 75: Regeneron Pharmaceuticals – Organizational development
Exhibit 76: Regeneron Pharmaceuticals – Segment focus
Exhibit 77: Regeneron Pharmaceuticals – Key offerings
Exhibit 78: Regeneron Pharmaceuticals – Key customers
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Alimera Sciences
  • ALLERGAN
  • Bausch Health
  • F. Hoffmann-La Roche
  • Regeneron Pharmaceuticals
  • MORE
New Report Released: - Global Diabetic Macular Edema Treatment Market 2018-2022

The author of the report recognizes the following companies as the key players in the global diabetic macular edema treatment market: ALLERGAN, Alimera Sciences, Bausch Health, F. Hoffmann-La Roche, and Regeneron Pharmaceuticals.

Commenting on the report, an analyst from the research team said: “One trend affecting this market is the use of new laser delivery systems. The redesign and replacement of the existing retinal delivery systems may result in better outcomes for the patients as these systems allow more precision and controlled allocation of rays.”

According to the report, one driver influencing this market is the increase in R&D investments by pharmaceutical companies. There is a surge in investments for research and developments being made by the leading pharmaceutical companies for the development of new drugs for the treatment of diabetic macular edema.

Further, the report states that one challenge affecting this market is the lack of awareness. One of the most major challenges being faced by the vendors of the global diabetic macular edema market is the lack of awareness about the disease.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • ALLERGAN
  • Alimera Sciences
  • Bausch Health
  • F. Hoffmann-La Roche
  • Regeneron Pharmaceuticals
Note: Product cover images may vary from those shown
Adroll
adroll